Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GILEAD SCIENCES, INC. Director's Dealing 2014

Dec 3, 2014

29828_dirs_2014-12-03_b60172dd-173d-4b71-a913-2a2a0180029f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2014-12-01

Reporting Person: WILSON GAYLE E (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-01 Common Stock M 2086 Acquired 40865 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-12-01 Phantom Shares $0 M 2088.7041 Acquired Common Stock (2088.7041) Direct

Footnotes

F1: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

F2: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3: An aggregate of 2088.7041 shares were reported in Table II when reporting person acquired the phantom shares. The fractional share of 2.7041 was paid out in cash in connection with the conversion into shares of common stock.